ImmunityBio, Inc. IBRX Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s change in accrued liabilities?
- ImmunityBio, Inc. (IBRX) reported change in accrued liabilities of $3.14M in Q1 2026.
- How has ImmunityBio, Inc.'s change in accrued liabilities changed year-over-year?
- ImmunityBio, Inc.'s change in accrued liabilities increased by 124.3% year-over-year, from -$12.93M to $3.14M.